Featured Research

from universities, journals, and other organizations

Decoded: DNA of blood-sucking worm that infects world's poor

Date:
January 19, 2014
Source:
Washington University in St. Louis
Summary:
Researchers have decoded the genome of the hookworm, Necator americanus, finding clues to how it infects and survives in humans and to aid in development of new therapies to combat hookworm disease.

Researchers have decoded the genome of the hookworm, Necator americanus, finding clues to how it infects and survives in humans and to aid in development of new therapies. An estimated 700 million people worldwide are infected with hookworms, which feed on blood, causing anemia and, in children, stunted growth and learning problems.
Credit: Peter Durbin

Going barefoot in parts of Africa, Asia and South America contributes to hookworm infections, which afflict an estimated 700 million of the world's poor. The parasitic worm lives in the soil and enters the body through the feet. By feeding on victims' blood, the worms cause anemia and, in children, stunted growth and learning problems.

Now, researchers at Washington University School of Medicine in St. Louis have decoded the genome of the hookworm, Necator americanus, finding clues to how it infects and survives in humans and to aid in development of new therapies to combat hookworm disease.

The research is published Jan. 19 in Nature Genetics.

"We now have a more complete picture of just how this worm invades the body, begins feeding on the blood and successfully evades the host immune defenses," said senior author Makedonka Mitreva, PhD, assistant professor of medicine and of genetics and a member of The Genome Institute at the School of Medicine. "This information will accelerate development of new diagnostic tools and vaccines against the infection."

Mitreva Necator americanus causes about 85 percent of human hookworm infections, which are not usually fatal. However, in pregnant women, the worm can cause severe anemia, leading to maternal deaths and low birth weights that contribute to newborn deaths.

The deworming drug albendazole typically is given as part of mass treatment programs in areas with endemic infection, but its repeated and excessive use is leading to treatment failures and drug resistance in some regions, Mitreva said.

Hookworms are common in areas of extreme poverty that lack indoor plumbing. The worm's eggs are excreted in the feces of infected individuals, contaminating the soil. After the eggs hatch, the immature worms, called larvae, molt twice and enter the body through the feet. The worms travel through the bloodstream to the lungs, where they are coughed up and then swallowed, making their way to the small intestine. It is there that the worms mature and begin feeding on the blood.

As part of the new research, the scientists took a multipronged approach to understand different aspects of how the hookworm invades the body, feeds on the blood and evades the host's immune system.

Decoding the worm's genome allowed the researchers to discover suites of genes that orchestrate each of these processes and to identify specific targets that may be vulnerable to vaccines or new drug treatments.

"We also prioritized those drug targets so that scientists can quickly follow up on the ones that appear to be most promising," Mitreva said.

While causing significant illness in developing countries, hookworms are garnering attention in the United States and other industrial countries for their therapeutic potential in the treatment of autoimmune conditions, such as inflammatory bowel disease, multiple sclerosis, asthma and even allergies.

As part of their research, the scientists identified a group of molecules that appears to protect the worm from detection by the host immune system.

Hookworms evade notice by suppressing molecules that promote inflammation. This same approach may prove valuable in the treatment of autoimmune conditions.

"It is our hope that the new research can be used as a springboard not just to control hookworm infections but to identify anti-inflammatory molecules that have the potential to advance new therapies for autoimmune and allergic diseases," Mitreva said.


Story Source:

The above story is based on materials provided by Washington University in St. Louis. Note: Materials may be edited for content and length.


Journal Reference:

  1. Yat T Tang, Xin Gao, Bruce A Rosa, Sahar Abubucker, Kymberlie Hallsworth-Pepin, John Martin, Rahul Tyagi, Esley Heizer, Xu Zhang, Veena Bhonagiri-Palsikar, Patrick Minx, Wesley C Warren, Qi Wang, Bin Zhan, Peter J Hotez, Paul W Sternberg, Annette Dougall, Soraya Torres Gaze, Jason Mulvenna, Javier Sotillo, Shoba Ranganathan, Elida M Rabelo, Richard K Wilson, Philip L Felgner, Jeffrey Bethony, John M Hawdon, Robin B Gasser, Alex Loukas, Makedonka Mitreva. Genome of the human hookworm Necator americanus. Nature Genetics, 2014; DOI: 10.1038/ng.2875

Cite This Page:

Washington University in St. Louis. "Decoded: DNA of blood-sucking worm that infects world's poor." ScienceDaily. ScienceDaily, 19 January 2014. <www.sciencedaily.com/releases/2014/01/140119142351.htm>.
Washington University in St. Louis. (2014, January 19). Decoded: DNA of blood-sucking worm that infects world's poor. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2014/01/140119142351.htm
Washington University in St. Louis. "Decoded: DNA of blood-sucking worm that infects world's poor." ScienceDaily. www.sciencedaily.com/releases/2014/01/140119142351.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins